Abeona Therapeutics Inc. ( ABEO) - Stock Earnings
ABEO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -20.5 million USD | 5.4 million USD |
| 2026Q1 | -17.1 million USD | 8.7 million USD |
| 2026Q2 | -20.2 million USD | 11.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ABEO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -54.2 million USD | 3.5 million USD |
| 2024 | -63.7 million USD | — USD |
| 2025 | 71.2 million USD | 5.8 million USD |
| 2026 Est. | — | — |
ABEO
Price: $4.96
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 254600
Ebitda: -5.2 millionMarket Capitalization: 293.5 million